U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices Voted Against Allowing Covid-19 Booster Vaccines for People whose Jobs or Situations Put Them at High Risk revolutionary infections.
ACIP voted 9-6 against the question: “A single booster dose of Pfizer-BioNTech Covid-19 vaccine is recommended based on individual benefits and risks for people aged 18 to 64 who are in a professional or institutional setting where the burden of Covid-19 infection and risk of transmission is high, at least six months after the primary series under the emergency use clearance from the FDA.
These could have included frontline workers, healthcare workers, caregivers for frail or immunocompromised people, people in homeless shelters and people in correctional facilities, the CDC said.
ACIP members discussed before voting.
“We can just as well say give it to anyone who is 18 and over,” said Dr. Pablo Sanchez, professor of pediatrics at Ohio State University.
“I feel very uncomfortable about this,” said Dr. Wilbur Chen, professor of medicine at the University of Maryland School of Medicine. “The implementation part of this is going to be so complex that the people with the best health literacy will get reminders. “
But ACIP President Dr Grace Lee, a pediatrician at Stanford University, said her personal experience made her realize the need to make boosters widely available.
“I have cared for children who died from Covid,” she said. “Their family members want extra protection for their children. “
Earlier Thursday: ACIP voted to recommend recalls for people 65 years of age and older and people 50 to 64 years of age with underlying health conditions.
This was under the FDA’s emergency use clearance, which agreed to give recalls to anyone 18 years of age and over at high risk of serious illness from breakthrough infections. Rather, ACIP limited its recommendation to people over 50 with such conditions after members expressed doubts about the overly broad recommendation of boosters.
So the staff added a third question that would allow a younger group to access the boosters. Members were less enthusiastic about this option but voted 9-6 to recommend it.